RT Journal Article
SR Electronic
T1 Personalised structural connectomics for moderate-to-severe traumatic brain injury
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.03.02.22271654
DO 10.1101/2022.03.02.22271654
A1 Imms, Phoebe
A1 Clemente, Adam
A1 Deutscher, Evelyn
A1 Radwan, Ahmed M.
A1 Akhlaghi, Hamed
A1 Beech, Paul
A1 Wilson, Peter H
A1 Irimia, Andrei
A1 Poudel, Govinda
A1 Domínguez D, Juan F
A1 Caeyenberghs, Karen
YR 2022
UL http://medrxiv.org/content/early/2022/03/04/2022.03.02.22271654.abstract
AB Graph theoretical analysis of the structural connectome has been employed successfully to characterise brain network alterations in patients with traumatic brain injury (TBI). However, heterogeneity in neuropathology is a well-known issue in the TBI population, such that group comparisons of patients against controls are confounded by within-group variability. Recently, novel single-subject profiling approaches have been developed to capture inter-patient heterogeneity. We present a personalised connectomics approach that examines structural brain alterations in six chronic patients with moderate-to-severe TBI who underwent anatomical and diffusion magnetic resonance imaging (MRI). We generated individualised profiles of lesion characteristics and network measures (including personalised graph metric ‘GraphMe’ plots, and nodal and edge-based brain network alterations) and compared them against healthy reference cases (N=12) to assess brain damage qualitatively and quantitatively at the individual level. Our findings revealed clinically significant alterations of brain networks with high variability between patients. Our profiling can be used by clinicians to formulate a neuroscience-guided integrative rehabilitation program for TBI patients, and for designing personalised rehabilitation protocols based on their unique lesion load and connectome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by an Australian Catholic University Research Fund [#902915].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the St Vincents Hospital Melbourne ethics committee for human research (project #250/17).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors